Headspace App

Personalized support starts here

Aurora, living life with Dravet syndrome

ONWARD logo. Taking support to the next levelWhether you simply have a few questions about FINTEPLA or have a loved one who is already on treatment, the ONWARD™ Support Program provides dedicated one-on-one support to help move you forward.

Considering FINTEPLA?

Already on FINTEPLA?

Considering FINTEPLA?

ONWARD has resources to help get you going in the right direction

FINTEPLA Clinical Nurse Educators (CNEs) are registered nurses and experts in Dravet syndrome and LGS who can answer any questions you have, as well as provide treatment education for families before starting FINTEPLA.* They can:

  • Prepare you for conversations with your loved one’s doctor
  • Discuss results of the FINTEPLA clinical studies and what they may mean for your family
  • Answer your questions about the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS)
  • Educate you on financial support programs for access to FINTEPLA treatment and echocardiogram tests

*FINTEPLA CNEs cannot provide medical advice or make treatment recommendations. They can only provide information about FINTEPLA. Decisions regarding your loved one’s health and the treatment of their condition should be made with their healthcare provider.

Talk to a CNE anytime between 7:30 am – 4:30 pm Central Time, Monday through Friday, at 1-833-463-7547 (1-833-GO-DS-LGS).

Can’t talk now? Leave your information here to receive a call from a CNE at a time that’s more convenient for you.

More ways to connect, anytime and anywhere

You can also talk to our 24/7 virtual assistant, Faye, when you have questions about FINTEPLA. Faye has been trained by FINTEPLA experts to help save you valuable time by answering questions you may have.

Let’s chat

Already on FINTEPLA?

ONWARD offers comprehensive support from Day 1 to simplify your journey

Care Coordinators are registered nurses trained in Dravet syndrome, LGS, and treatment with FINTEPLA. Once enrolled in ONWARD, every family is given a dedicated Care Coordinator who will reach out and help you and your loved one start and stay on treatment. Your coordinator will:

  • Review insurance coverage with you, keep you informed of your approval status, and offer options
  • Explain what to expect, provide guidance with treatment reminders, and help find echocardiogram locations near you
  • Connect with a specialty pharmacy to get your loved one’s treatment
  • Work with you and your healthcare provider to create a personalized plan that keeps your loved one on track

Once enrolled, you can call your Care Coordinator 7 am – 7 pm Central Time, Monday through Friday, at 1-888-964-3649.

ONWARD is provided as a service of UCB and is intended to support the appropriate use of UCB medicines.

ONWARD may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.

Financial support for FINTEPLA

UCB is dedicated to making FINTEPLA available and affordable for every eligible patient.

Explore the options

FINTEPLA FAQs

Find answers to common questions that families ask about FINTEPLA.

Explore FAQs

Stay Informed

Interested in receiving helpful information about FINTEPLA and Dravet syndrome or Lennox-Gastaut syndrome (LGS)?
Register below to personally receive support resources, inspiring patient stories, educational content, and more.

The fields marked with an asterisk (*) are mandatory.

I am interested in learning more about:*

Please select one.
Which of the following best describes you?*

Indication

Read more +

  • FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.
  • It is not known if FINTEPLA is safe and effective in children less than 2 years of age.

Important Safety Information

FINTEPLA can cause serious side effects, including:

  1. 1.Problems with the valves in the heart (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension) have been associated with FINTEPLA. Your healthcare provider will do a test called an echocardiogram to check your heart and to evaluate for high blood pressure in the arteries of the lungs before you start taking FINTEPLA, again every 6 months during treatment, and one time 3 to 6 months after you take your last dose of FINTEPLA.

    Call your healthcare provider right away if you develop any of these signs and symptoms of heart or lung problems during treatment with FINTEPLA:

    • shortness of breath
    • tiredness or weakness, especially with increased activity
    • lightheadedness or fainting
    • swollen ankles or feet
    • chest pain
    • sensations of a rapid, fluttering heartbeat (palpitations)
    • irregular pulse
    • bluish color of your lips and skin (cyanosis)

    Because of the risk of heart valve problems (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension), FINTEPLA is only available through a restricted program called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS). Before you or your child receives FINTEPLA, your healthcare provider or pharmacist will make sure you understand how to take FINTEPLA safely. If you have any questions about FINTEPLA, ask your healthcare provider, visit www.FinteplaREMS.com, or call 1-877-964-3649.

  2. 2. Decreased appetite and decreased weight. Decreased appetite and decreased weight are serious and common side effects of FINTEPLA.

    • Your weight should be checked regularly during your treatment with FINTEPLA.
    • Your healthcare provider may need to make changes to your FINTEPLA dose if your weight decreases. In some cases, FINTEPLA may need to be stopped.

  3. 3. Sleepiness, sedation, and lack of energy (lethargy). These are serious and common side effects of FINTEPLA. Taking FINTEPLA with central nervous system (CNS) depressants, including alcohol, may increase sleepiness. Do not drive, operate heavy machinery, or do other dangerous activities until you know how FINTEPLA affects you.

  4. 4. Like all other antiepileptic drugs, FINTEPLA may cause suicidal thoughts or actions in a very small number of people (about 1 in 500). Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; trouble sleeping (insomnia); attempts to commit suicide; new or worse irritability; new or worse depression; acting aggressive, being angry or violent; new or worse anxiety; acting on dangerous impulses; feeling agitated or restless; an extreme increase in activity and talking (mania); panic attacks; other unusual changes in behavior or mood.

    How can I watch for early symptoms of suicidal thoughts and actions?

    Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled.

    Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.

  5. 5. Do not stop taking FINTEPLA without first talking to your healthcare provider. Stopping a seizure medicine such as FINTEPLA can suddenly cause you to have seizures more often or seizures that do not stop (status epilepticus).

    Do not take FINTEPLA if you:

    • are allergic to fenfluramine or any of the ingredients in FINTEPLA. See the Medication Guide for a complete list of ingredients in FINTEPLA.
    • are taking or have stopped taking medicines called monoamine oxidase inhibitors (MAOIs) in the last 14 days. This may cause a serious or life-threatening problem called serotonin syndrome. If you are not sure whether or not you are taking one of these medicines, contact your healthcare provider.

    Before taking FINTEPLA, tell your healthcare provider about all of your medical conditions, including heart problems; weight loss; depression, mood problems, or suicidal thoughts or behavior; kidney problems; liver problems; are pregnant or plan to become pregnant; are breastfeeding or plan to breastfeed.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of FINTEPLA?

    FINTEPLA may cause serious side effects, including:

    • See “FINTEPLA can cause serious side effects” above

    • Serotonin syndrome. Serotonin syndrome is a life-threatening problem that can happen in people taking FINTEPLA, especially if FINTEPLA is taken with certain other medicines, including anti-depressant medicines called SSRIs, SNRIs, TCAs, and MAOIs; tryptophan; lithium; antipsychotics; St. John’s Wort; dextromethorphan; tramadol.

      Call your healthcare provider right away if you have any of the following symptoms of serotonin syndrome: mental status changes such as seeing things that are not there (hallucinations), agitation, or coma; changes in blood pressure; tight muscles; fast heartbeat; nausea, vomiting, or diarrhea; high body temperature; trouble walking.

    • High blood pressure (hypertension). Hypertension is a serious and common side effect. FINTEPLA can cause your blood pressure to increase even if you have never had high blood pressure before.

    • Increased pressure in your eyes (glaucoma). Symptoms of glaucoma may include red eyes, seeing halos or bright colors around lights, nausea or vomiting, decreased vision, eye pain or discomfort, blurred vision.

      If you have any of these symptoms, call your healthcare provider right away.

The most common side effects of FINTEPLA when used to treat patients with Dravet syndrome (DS) include decreased appetite; diarrhea; low energy; respiratory infection; decreased weight; fever; constipation; abnormal echocardiogram; sleepiness; problems with movement, balance, and walking; increased drooling; increased blood pressure; vomiting; falls; seizures that do not stop; weakness.

The most common side effects of FINTEPLA when used to treat patients with Lennox-Gastaut syndrome (LGS) include diarrhea; tiredness; vomiting; sleepiness; decreased appetite.

Indication

Read more +

  • FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.
  • It is not known if FINTEPLA is safe and effective in children less than 2 years of age.

These are not all the possible side effects of FINTEPLA. For more information, ask your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Keep FINTEPLA and all medicines out of the reach of children.

Please see full Prescribing Information, including Medication Guide, for additional Important Safety Information on FINTEPLA.